Loading...
Products:Cardiovascular >> Lipids / Lipoproteins >> Adipose Related >> Acrp
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-Adiponectin antibody [19F1]
See all Adiponectin products (25) ...
Mouse monoclonal [19F1] to Adiponectin
IF, ELISA, ICC/IF, ICC, IHC-P, WBmore details
Reacts with
Mouse, Human, Baboon
Recombinant full length protein (Human).
3T3-L1 adipocytes
Liquid
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.05% Sodium Azide
Constituents: PBS, 1mg/ml BSA
Concentration information loading...
Protein G purified
Monoclonal
19F1
IgG
Metabolism >> Types of disease >> Metabolic disorders
Metabolism >> Types of disease >> Heart disease
Metabolism >> Types of disease >> Cancer
Metabolism >> Types of disease >> Obesity
Metabolism >> Types of disease >> Diabetes
Metabolism >> Pathways and Processes >> Metabolism processes >> Hypoxia
Cancer >> Cancer Metabolism >> Response to hypoxia
Cardiovascular >> Atherosclerosis >> Diabetes associated
Stem Cells >> Mesenchymal Stem Cells >> Adipogenesis
Neuroscience >> Neurology process >> Metabolism
Signal Transduction >> Growth Factors/Hormones >> Hormones
Cardiovascular >> Lipids / Lipoproteins >> Adipose Related >> Acrp
Our Abpromise guarantee covers the use of ab22554 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ELISA: Use at an assay dependent dilution.
ICC: Use at an assay dependent dilution (PMID 19657392).
IF: Use at a concentration of 2 - 4 µg/ml.
IHC-P: Use at an assay dependent concentration.
WB: Use at a concentration of 1 µg/ml. Detects a band of approximately 30 kDa (predicted molecular weight: 26 kDa).
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Important adipokine involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic and anti-inflammatory activities. Stimulates AMPK phosphorylation and activation in the liver and the skeletal muscle, enhancing glucose utilization and fatty-acid combustion. Antagonizes TNF-alpha by negatively regulating its expression in various tissues such as liver and macrophages, and also by counteracting its effects. Inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. May play a role in cell growth, angiogenesis and tissue remodeling by binding and sequestering various growth factors with distinct binding affinities, depending on the type of complex, LMW, MMW or HMW.
Synthesized exclusively by adipocytes and secreted into plasma.
Defects in ADIPOQ are the cause of adiponectin deficiency (ADPND) [MIM:612556]. ADPND results in very low concentrations of plasma adiponectin.
Genetic variations in ADIPOQ are associated with non-insulin-dependent diabetes mellitus (NIDDM) [MIM:125853]; also known as diabetes mellitus type 2. NIDDM is characterized by an autosomal dominant mode of inheritance, onset during adulthood and insulin resistance.
Contains 1 C1q domain.
Contains 1 collagen-like domain.
The C1q domain is commonly called the globular domain.
Hydroxylated Lys-33 was not identified in PubMed:16497731, probably due to poor representation of the N-terminal peptide in mass fingerprinting.
HMW complexes are more extensively glycosylated than smaller oligomers. Hydroxylation and glycosylation of the lysine residues within the collagene-like domain of adiponectin seem to be critically involved in regulating the formation and/or secretion of HMW complexes and consequently contribute to the insulin-sensitizing activity of adiponectin in hepatocytes.
O-glycosylated. Not N-glycosylated. O-linked glycans on hydroxylysines consist of Glc-Gal disaccharides bound to the oxygen atom of post-translationally added hydroxyl groups. Sialylated to varying degrees depending on tissue. Thr-22 appears to be the major site of sialylation. Higher sialylation found in SGBS adipocytes than in HEK fibroblasts. Sialylation is not required neither for heterodimerization nor for secretion. Not sialylated on the glycosylated hydroxylysines. Desialylated forms are rapidly cleared from the circulation.
Secreted.
Target information above from: UniProt accessionQ15848
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - Adiponectin antibody [19F1] (ab22554)
![Western blot - Adiponectin antibody [19F1] (ab22554)](/ps/datasheet/Images/22/ab22554/ab22554.jpg)
Anti-Adiponectin antibody [19F1] (ab22554) at 1 µg/ml +
Predicted band size : 26 kDa
Observed band size : 30 kDa (why is the actual band size different from the predicted?)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Adiponectin antibody [19F1] (ab22554)
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Adiponectin antibody [19F1] (ab22554)](/ps/datasheet/images/22/ab22554/Adiponectin-Primary-antibodies-ab22554-3.jpg)
ab22554 staining Adiponectin in Mouse skin tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde and blocked with 10% serum for 1 hour at 20°C; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody (1/100) for 12 hours at 4°C. A Biotin-conjugated Rabbit anti-mouse polyclonal (1/200) was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Adiponectin antibody [19F1](ab22554)
](/ps/datasheet/images/22/ab22554/Adiponectin-Primary-antibodies-ab22554-4.jpg)
ab22554 (4µg/ml) staining adiponectin in human breast, using an automated system (DAKO Autostainer Plus). Using this protocol there is nuclear and cytoplasmic staining.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
Immunocytochemistry/ Immunofluorescence - Adiponectin antibody [19F1] (ab22554)
![Immunocytochemistry/ Immunofluorescence - Adiponectin antibody [19F1] (ab22554)](/ps/datasheet/images/22/ab22554/Adiponectin-Primary-antibodies-ab22554-7.jpg)
ab22554 staining Adiponectin in human adipose stem cells by Immunocytochemistry/ Immunofluorescence. The cells were fixed in paraformaldehyde, permeabilised in 0.1% Triton X and then blocked using 4% serum for 1 hour. Samples were then incubated with primary antibody at 1/500 for 1 hour 30 minutes. The secondary antibody used was a goat IgG conjugated to Alexa Fluor® 488 (green) used at a 1/500 dilution.
Image courtesy of an anonymous Abreview.
This product has been referenced in:
See all 7 publications for this product
Publishing research using ab22554? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Adiponectin antibody [19F1] (ab22554)](/ps/datasheet/images/22/ab22554/Adiponectin-Primary-antibodies-ab22554-3.jpg)
ab22554 staining Adiponectin in Mouse skin tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde and blocked with 10% serum for 1 hour at 20°C; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody (1/100) for 12 hours at 4°C. A Biotin-conjugated Rabbit anti-mouse polyclonal (1/200) was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
](/ps/datasheet/images/22/ab22554/Adiponectin-Primary-antibodies-ab22554-4.jpg)
ab22554 (4µg/ml) staining adiponectin in human breast, using an automated system (DAKO Autostainer Plus). Using this protocol there is nuclear and cytoplasmic staining.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
![Immunocytochemistry/ Immunofluorescence - Adiponectin antibody [19F1] (ab22554)](/ps/datasheet/images/22/ab22554/Adiponectin-Primary-antibodies-ab22554-7.jpg)
ab22554 staining Adiponectin in human adipose stem cells by Immunocytochemistry/ Immunofluorescence. The cells were fixed in paraformaldehyde, permeabilised in 0.1% Triton X and then blocked using 4% serum for 1 hour. Samples were then incubated with primary antibody at 1/500 for 1 hour 30 minutes. The secondary antibody used was a goat IgG conjugated to Alexa Fluor® 488 (green) used at a 1/500 dilution.
Image courtesy of an anonymous Abreview.
![Adiponectin antibody [19F1] for Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) in Mouse (22554)](/ps/datasheet/images/22/ab22554/Adiponectin-Primary-antibodies-ab22554-2.jpg)
4
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
